HIP2101 / Hanmi  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
HIP2101 / Hanmi
NCT04967014: Study to Evaluate the Safety and Pharmacodynamic/Pharmacokinetic Characteristics of HIP2101 in Healthy Volunteers

Completed
1
32
RoW
HIP2101, RLD2101
Hanmi Pharmaceutical Company Limited
Healthy Adult Volunteer
06/21
06/21

Download Options